Geostrategic magazine

L’Indonesia e il vaccino COVID-19 di produzione nazionale

Dall’analisi di Andree Surianta, East Asia Forum: On 13 September 2022, Indonesian President Joko ‘Jokowi’ Widodo officially introduced the country’s first domestically produced COVID-19 vaccine. The protein subunit vaccine — branded IndoVac — was hailed as an important milestone in the country’s efforts to achieve vaccine self-sufficiency since it comprises nearly 80 per cent local ingredients. That is a great success for a country that has imported all 400 million doses of its COVID-19 vaccines. It also seems to vindicate the 130-year-old state-owned vaccine producer, Bio Farma, which was likened to a ‘vaccine tailor’ for its bulk import and repackaging deal with China’s Sinovac. Bio Farma is now mulling plans to export and donate this ‘home-grown’ vaccine to African countries. The company’s status as the largest polio vaccine exporter in the world makes this ambition feasible.

Indonesia’s slow path to vaccine self-sufficiency | East Asia Forum